Scott Bizily insider trades
Open-market stock purchases and sales by Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc, from SEC Form 4 filings since Jun 18, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $21K |
| Oct 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $6.8K |
| Oct 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $22.3K |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $6.8K |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $3.8K |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $8.2K |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Aug 17, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $19.9K |
| Aug 17, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Aug 17, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $6.8K |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $19.6K |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $6.8K |
| Jun 30, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $91.9K |
| Jun 30, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $3.4K |
| Jun 30, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | $37.3K |
| Jun 30, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Jun 30, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Jun 23, 2026 | FDMT 4D Molecular Therapeutics, Inc | Sold | $118K |
| Jun 23, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Mar 25, 2026 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |
| Dec 16, 2025 | FDMT 4D Molecular Therapeutics, Inc | Sold | $17.8K |
| Dec 16, 2025 | FDMT 4D Molecular Therapeutics, Inc | Bought (not open market) | — |